Literature DB >> 26722492

Decreased calcitonin gene-related peptide expression in the dorsal root ganglia of TNF-deficient mice in a monoiodoacetate-induced knee osteoarthritis model.

Aya Taniguchi1, Tetsuhiro Ishikawa2, Masayuki Miyagi3, Hiroto Kamoda1, Yoshihiro Sakuma2, Yasuhiro Oikawa2, Go Kubota2, Kazuhide Inage2, Takeshi Sainoh2, Junichi Nakamura2, Yasuchika Aoki4, Tomoaki Toyone5, Gen Inoue3, Miyako Suzuki2, Kazuyo Yamauchi2, Takane Suzuki6, Kazuhisa Takahashi2, Seiji Ohtori2, Sumihisa Orita2.   

Abstract

BACKGROUND: The detailed mechanisms of knee osteoarthritis (OA) pain have not been clarified, but involvement of inflammatory cytokines such as tumor necrosis factor-alpha (TNF) has been suggested. The present study aimed to investigate the more detailed neurological involvement of TNF in joint pain using a TNF-knockout mouse OA model.
METHODS: The right knees of twelve-week-old C57BL/6J wild and TNF-deficient knockout (TNF-ko) mice (n=15, each group) were given a single intra-articular injection of 10 µg monoiodoacetate in 10 mL sterile saline. The left knees were only punctured as the control. Evaluations were performed immediately after the injection (baseline) and at 7, 14, and 28 days after the injection with a subsequent intra-articular injection of neurotracer into both knees. The animals were evaluated for immunofluorescence of the lumbar dorsal root ganglia (DRG) innervating the knee joints. The injected knees were observed macroscopically and mouse pain-related behaviors were scored.
RESULTS: Macroscopic observation showed similar knee OA development in both wild and TNF-ko mice. Calcitonin gene-related peptide (CGRP, a neuropeptide identified as a inflammatory pain-related biomarker) was significantly increased in DRG neurons innervating OA-induced knee joints with significantly less CGRP expression in TNF-ko animals. Pain-related behavior scoring showed a significant increase in pain in OA-induced joints, but there was no significant difference in pain observed between the wild and TNF-ko mice.
CONCLUSIONS: The result of the present study indicates the possible association of TNF-alpha in OA pain but not OA development.

Entities:  

Keywords:  Osteoarthritis; mice model; monoiodoacetate (MIA); tumor necrosis factor (TNF)-alpha

Mesh:

Substances:

Year:  2015        PMID: 26722492      PMCID: PMC4680437     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  9 in total

1.  Spinal injection of TNF-α-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1.

Authors:  Yong-Jing Gao; Ling Zhang; Ru-Rong Ji
Journal:  Glia       Date:  2010-11-15       Impact factor: 7.452

2.  Tumor necrosis factor causes persistent sensitization of joint nociceptors to mechanical stimuli in rats.

Authors:  Frank Richter; Gabriel Natura; Stefan Löser; Katarina Schmidt; Hanna Viisanen; Hans-Georg Schaible
Journal:  Arthritis Rheum       Date:  2010-12

3.  Effective knock down of matrix metalloproteinase-13 by an intra-articular injection of small interfering RNA (siRNA) in a murine surgically-induced osteoarthritis model.

Authors:  Ryuichiro Akagi; Takahisa Sasho; Masahiko Saito; Jun Endo; Satoshi Yamaguchi; Yuta Muramatsu; Shunsuke Mukoyama; Yorikazu Akatsu; Joe Katsuragi; Taisuke Fukawa; Kazuhisa Takahashi
Journal:  J Orthop Res       Date:  2014-05-22       Impact factor: 3.494

4.  Changes in pain behavior and histologic changes caused by application of tumor necrosis factor-alpha to the dorsal root ganglion in rats.

Authors:  Yasuaki Murata; Akira Onda; Björn Rydevik; Ichiro Takahashi; Kazuhisa Takahashi; Kjell Olmarker
Journal:  Spine (Phila Pa 1976)       Date:  2006-03-01       Impact factor: 3.468

Review 5.  The role of proinflammatory cytokines in the generation and maintenance of joint pain.

Authors:  H-G Schaible; G Segond von Banchet; M K Boettger; R Bräuer; M Gajda; F Richter; S Hensellek; D Brenn; G Natura
Journal:  Ann N Y Acad Sci       Date:  2010-04       Impact factor: 5.691

6.  Detection of pain-related molecules in the subchondral bone of osteoarthritic knees.

Authors:  Shuhei Ogino; Takahisa Sasho; Koichi Nakagawa; Masahiko Suzuki; Satoshi Yamaguchi; Morihiro Higashi; Kazuhisa Takahashi; Hideshige Moriya
Journal:  Clin Rheumatol       Date:  2009-12       Impact factor: 2.980

7.  Associations between proinflammatory cytokines in the synovial fluid and radiographic grading and pain-related scores in 47 consecutive patients with osteoarthritis of the knee.

Authors:  Sumihisa Orita; Takana Koshi; Takeshi Mitsuka; Masayuki Miyagi; Gen Inoue; Gen Arai; Tetsuhiro Ishikawa; Eiji Hanaoka; Keishi Yamashita; Masaomi Yamashita; Yawara Eguchi; Tomoaki Toyone; Kazuhisa Takahashi; Seiji Ohtori
Journal:  BMC Musculoskelet Disord       Date:  2011-06-30       Impact factor: 2.362

8.  Pain-related sensory innervation in monoiodoacetate-induced osteoarthritis in rat knees that gradually develops neuronal injury in addition to inflammatory pain.

Authors:  Sumihisa Orita; Tetsuhiro Ishikawa; Masayuki Miyagi; Nobuyasu Ochiai; Gen Inoue; Yawara Eguchi; Hiroto Kamoda; Gen Arai; Tomoaki Toyone; Yasuchika Aoki; Takekazu Kubo; Kazuhisa Takahashi; Seiji Ohtori
Journal:  BMC Musculoskelet Disord       Date:  2011-06-16       Impact factor: 2.362

9.  Increasing expression of substance P and calcitonin gene-related peptide in synovial tissue and fluid contribute to the progress of arthritis in developmental dysplasia of the hip.

Authors:  Hui Wang; Xiang Zhang; Ji-Ye He; Xin-Feng Zheng; De Li; Zheng Li; Jun-Feng Zhu; Chao Shen; Gui-Quan Cai; Xiao-Dong Chen
Journal:  Arthritis Res Ther       Date:  2015-01-12       Impact factor: 5.156

  9 in total
  2 in total

Review 1.  The innate immune response as a mediator of osteoarthritis pain.

Authors:  R J Miller; A-M Malfait; R E Miller
Journal:  Osteoarthritis Cartilage       Date:  2019-12-17       Impact factor: 6.576

2.  Development of chimeric and bifunctional antagonists for CLR/RAMP receptors.

Authors:  Chia Lin Chang; Sheau Yu Teddy Hsu
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.